Cancer Treatment and Research Communications (Jan 2022)

Invited commentary on “Thyrotropin Suppression therapy Using Levothyroxine Does Not Negatively Affect Breast Cancer Prognosis”

J.N. Kolla

Affiliations

J.N. Kolla: Corresponding author.; Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Journal volume & issue: Vol. 31
p. 100567

Abstract

No abstracts available.

Published in Cancer Treatment and Research Communications

ISSN: 2468-2942 (Online)
Publisher: Elsevier
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.journals.elsevier.com/cancer-treatment-and-research-communications

About the journal